We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
426
PUT
Linde
LIN
$221B
| $88.6M | 0.05% |
305,100
+180,200
| +144% | +$52.5M |
|
427
Check Point Software Technologies
CHKP
$13B
| $88.5M | 0.05% |
761,759
+29,848
| +4% | +$3.52M |
|
428
Delta Air Lines
DAL
$57.5B
| $88.2M | 0.05% |
2,056,427
-308,591
| -13% | -$14.3M |
|
429
Chegg
CHGG
$110M
| $87.9M | 0.05% |
1,035,304
-18,795
| -2% | -$1.56M |
|
430
Fate Therapeutics
FATE
$286M
| $87.5M | 0.05% |
1,007,783
+1,176
| +0.1% | +$94.8K |
|
431
PUT
Palantir
PLTR
$295B
| $87.4M | 0.05% |
3,283,400
+1,035,500
| +46% | +$23.9M |
|
432
CALL
Micron Technology
MU
$930B
| $87.1M | 0.05% |
1,025,500
-367,400
| -26% | -$31M |
|
433
C3.ai
AI
$1.43B
| $87.1M | 0.05% |
1,351,482
+1,052,361
| +352% | +$65.4M |
|
434
CALL
Home Depot
HD
$331B
| $86.8M | 0.05% |
272,900
-188,500
| -41% | -$60M |
|
435
PUT
Texas Instruments
TXN
$252B
| $86.8M | 0.05% |
451,600
-487,800
| -52% | -$91.4M |
|
436
PUT
Chevron
CVX
$392B
| $86.7M | 0.05% |
836,000
-580,500
| -41% | -$61.3M |
|
437
PUT
Comcast
CMCSA
$85B
| $86.7M | 0.05% |
1,521,200
-1,526,400
| -50% | -$85.3M |
|
|
TWOU
438
DELISTED
2U Inc
TWOU
| $86.7M | 0.05% |
69,347
+1,028
| +2% | +$1.19M |
|
|
NVRO
439
DELISTED
NEVRO CORP.
NVRO
| $86.6M | 0.05% |
523,178
-85,434
| -14% | -$13.3M |
|
440
Ametek
AME
$55.4B
| $86.6M | 0.05% |
650,874
-18,686
| -3% | -$2.5M |
|
441
Oneok
OKE
$57.2B
| $86.4M | 0.05% |
1,566,197
+315,106
| +25% | +$16.8M |
|
442
KLA
KLAC
$239B
| $86.2M | 0.05% |
2,659,420
-1,564,520
| -37% | -$50.1M |
|
443
PUT
Merck
MRK
$322B
| $86.1M | 0.05% |
1,115,700
-696,397
| -38% | -$51.8M |
|
444
iShares Global Tech ETF
IXN
$8.32B
| $85.7M | 0.05% |
1,523,700
| – | – |
|
445
Aflac
AFL
$64.9B
| $85.6M | 0.05% |
1,599,141
+130,743
| +9% | +$7.13M |
|
446
Deutsche Bank
DB
$69B
| $85.4M | 0.05% |
6,514,664
-10,743,541
| -62% | -$146M |
|
447
CALL
State Street SPDR S&P Bank ETF
KBE
$1.64B
| $84.4M | 0.04% |
1,644,900
+2,500
| +0.2% | +$133K |
|
|
BLUE
448
DELISTED
bluebird bio
BLUE
| $84.3M | 0.04% |
203,471
+24,256
| +14% | +$9.61M |
|
449
Zymeworks
ZYME
$1.61B
| $84.2M | 0.04% |
2,346,360
+54,871
| +2% | +$1.74M |
|
450
Southern Company
SO
$109B
| $83.6M | 0.04% |
1,382,689
-198,736
| -13% | -$12.7M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.